Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd

drug approvals

Food and Drug Administration
Pharma

Regulatory tracker: FDA starts review of Sandoz's generic GLP-1

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Open door symbolizing exit

CDER chief Høeg and CBER's Szarama exiting FDA posts

May 15, 2026 1:44pm
drug label warning

FDA floats approach to repurpose older drugs under new uses

May 14, 2026 9:31am
A photo finish at a horse race with both horses crossing the finish line

Pfizer, Arvinas' breast cancer med wins FDA approval

May 1, 2026 3:50pm
FDA

FDA approves leucovorin without clinical trial—but not for autism

Mar 10, 2026 9:00am
Blue background with pill pattern with the words The Top Line

Drug approvals went from crawl to sprint in 2025

Jan 16, 2026 10:00am